Bio-Rad Labs (BIO) PT Lowered to $477 at RBC Capital
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $356.26 -1.36%
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
RBC Capital analyst Conor McNamara lowered the price target on Bio-Rad Labs (NYSE: BIO) to $477.00 (from $481.00) while maintaining a Outperform rating.
You May Also Be Interested In
- JPMorgan Upgrades Resona Holdings, Inc (8308:JP) (RSNHF) to Overweight
- Deutsche Boerse AG (DB1:GR) (DBOEY) PT Raised to EUR252 at RBC Capital
- Bank of Ireland (BIRG:ID) (BKRIY) PT Raised to EUR16 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
